This PQI will discuss the use of oral avapritinib in patients with indolent systemic mastocytosis (ISM).
2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
Last Updated: July 14, 2025
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQI